It is FDA’s practice to issue Warning Letters in order to provide individuals and companies an opportunity to take voluntary and prompt corrective action before it initiates an enforcement action. The agency’s position is that it issues Warning Letters only for violations of regulatory significance. Significant violations are those violations that may lead to enforcement
More Posts
Senators propose taking Patients’ socio-economic status into account before penalizing hospitals for poor readmission metrics – COMPLIANCE
HHS proposed rule would extend time to meet next phase of E-Record meaningful use criteria
Seventh national Medicare Fraud Strike Force takedown results in charges against 90 individuals
HHS OIG proposes new approach to penalties for claims that are only partially fraudulent
CMS increases both payments to and penalties for inpatient hospitals for FY 2015
Medicare publishes physician-specific payment data, industry fears FCA claims will follow
Supreme Court declines to weigh in on split in the US courts of appeals over pleading requirements for FCA
GAO report calls out regulators: lack of standards impeding use of E-records systems
Representative McDermott urges RAC appeal fix
Subscribe: Subscribe via RSS
Firm/Org